Pasar al contenido principal

Desarrollo de un modelo porcino de toxoplasmosis y métodos de determinación de la viabilidad de Toxoplasma gondii en tejidos y productos cárnicos.

PTQ2019-010719

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprograma Subprograma Estatal de Incorporación
Convocatoria Torres Quevedo
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario SALUVET-INNOVA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A comparative study of eight serological methods shows that spike protein-based ELISAs are the most accurate tests for serodiagnosing SARS-CoV-2 infections in cats and dogs

  • Diezma-Díaz, Carlos
  • Álvarez-García, Gema
  • Regidor-Cerrillo, Javier
  • Miró, Guadalupe
  • Villanueva-Saz, Sergio
  • Pérez, María Dolores
  • Verde, María Teresa
  • Galán-Malo, Patricia
  • Brun Torres, Alejandro
  • Moreno, Sandra
  • Checa, Rocío
  • Montoya, Ana
  • Van Voorhis, Wesley C.
  • Ortega-Mora, Luis Miguel
13 Pág., Coronavirus disease 2019 (COVID-19) is an infectious zoonotic disease caused by SARS-CoV-2. Monitoring the infection in pets is recommended for human disease surveillance, prevention, and control since the virus can spread from people to animals during close contact. Several diagnostic tests have been adapted from humans to animals, but limited data on the validation process are available., This study was funded by a M granCOV20/01471-Ct from the Community of Madrid and a REACT-European Union grant from the Community of Madrid to the ANTICIPA project of the Complutense University of Madrid through the European Regional Development Fund as part of the Union's response to the COVID-19 pandemic. CD-D was funded by a grant from the Spanish Ministry of Economy and Enterprise (PTQ2019-010719). This study was also financially supported by the Zaragoza University through the PROGRAMA COVID19 SANTANDER UNIZAR: Proyectos de Innovación Tecnológica para el año 2020 de la Universidad de Zaragoza and by the United States National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, through NIH contract HHSN272201700059C., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

A comparative study of eight serological methods shows that spike protein-based ELISAs are the most accurate tests for serodiagnosing SARS-CoV-2 infections in cats and dogs

  • Diezma-Díaz, Carlos
  • Álvarez-García, Gema
  • Regidor-Cerrillo, Javier
  • Miró, Guadalupe
  • Villanueva Saz, Sergio
  • Pérez, María Dolores
  • Verde, María Teresa
  • Galán Malo, Patricia
  • Brun, Alejandro
  • Moreno, Sandra
  • Checa, Rocío
  • Montoya, Ana
  • Van Voorhis, Wesley C.
  • Ortega Mora, Luis Miguel
IntroductionCoronavirus disease 2019 (COVID-19) is an infectious zoonotic disease caused by SARS-CoV-2. Monitoring the infection in pets is recommended for human disease surveillance, prevention, and control since the virus can spread from people to animals during close contact. Several diagnostic tests have been adapted from humans to animals, but limited data on the validation process are available.MethodsHerein, the first comparative study of six “in house” and two commercial serological tests developed to monitor SARS-CoV-2 infection in pets was performed with a well-coded panel of sera (61 cat sera and 74 dog sera) with a conservative criterion (viral seroneutralisation and/or RT–qPCR results) as a reference. Four “in house” tests based on either the RBD fragment of the spike protein (RBD-S) or the N-terminal fragment of the nucleoprotein (N) were developed for the first time. The analytical specificity (ASp) of those tests that showed the best diagnostic performance was assessed. The validation included the analysis of a panel of sera obtained pre-pandemic from cats and dogs infected with other coronaviruses to determine the analytical Sp (17 cat sera and 41 dog sera).Results and discussionELISAS based on the S protein are recommended in serosurveillance studies for cats (RBD-S SALUVET ELISA, ELISA COVID UNIZAR and INgezim® COVID 19 S VET) and dogs (INgezim® COVID 19 S VET and RBD-S SALUVET ELISA). These tests showed higher diagnostic sensitivity (Se) and DSp in cats (>90%) than in dogs. When sera obtained prior to the pandemic and from animals infected with other coronaviruses were analyzed by RBD-S and N SALUVET ELISAs and INgezim® COVID 19 S VET, a few cross reactors or no cross reactions were detected when dog and cat sera were analyzed by tests based on the S protein, respectively. In contrast, the number of cross reactions increased when the test was based on the N protein. Thus, the use of tests based on the N protein was discarded for serodiagnosis purposes. The results obtained revealed the most accurate serological tests for each species. Further studies should attempt to improve the diagnostic performance of serological tests developed for dogs.